SIGNATURE RX Trademark

Trademark Overview

On Thursday, May 4, 2023, a trademark application was filed for SIGNATURE RX with the United States Patent and Trademark Office. The USPTO has given the SIGNATURE RX trademark a serial number of 97920185. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 28, 2025. This trademark is owned by PharmaPac Holdings. The SIGNATURE RX trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Contract manufacturing in the field of compounded pharmaceuticals
signature rx

General Information

Serial Number97920185
Word MarkSIGNATURE RX
Filing DateThursday, May 4, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2025

Trademark Statements

Goods and ServicesContract manufacturing in the field of compounded pharmaceuticals
Pseudo MarkSIGNATURE
NOT AVAILABLE"RX"

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, June 2, 2023
Primary Code040
First Use Anywhere DateWednesday, June 11, 2014
First Use In Commerce DateWednesday, June 11, 2014

Trademark Owner History

Party NamePharmaPac Holdings
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDelray Beach, FL 33444
Party NamePharmaPac Holdings
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDelray Beach, FL 33444

Trademark Events

Event DateEvent Description
Monday, May 8, 2023NEW APPLICATION ENTERED
Friday, June 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 23, 2024ASSIGNED TO EXAMINER
Thursday, January 25, 2024NON-FINAL ACTION WRITTEN
Thursday, January 25, 2024NON-FINAL ACTION E-MAILED
Thursday, January 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 20, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 20, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, June 25, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, June 25, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, June 25, 2024PETITION TO REVIVE-GRANTED
Tuesday, June 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 9, 2024ASSIGNED TO LIE
Thursday, October 10, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, October 10, 2024FINAL REFUSAL E-MAILED
Thursday, October 10, 2024FINAL REFUSAL WRITTEN
Tuesday, December 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 3, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, December 4, 2024NON-FINAL ACTION WRITTEN
Wednesday, December 4, 2024NON-FINAL ACTION E-MAILED
Wednesday, December 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 9, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 2, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 28, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

signature pharmaceuticals compounded field manufacturing contract